Genmab Phase 3 Epcoritamab Trial Meets Primary PFS Endpoint
COPENHAGEN, Denmark, June 29, 2026 Genmab A/S announced positive topline results from the Phase 3 EPCORE DLBCL-4 clinical trial...
Hematology
Advertisement
PharmaEssentia Secures FDA Approval for BESREMi Pen in Polycythemia Vera
BURLINGTON, Mass., June 26, 2026 PharmaEssentia USA Corporation announced that the U.S. Food and Drug Administration (FDA) has approved...
Star Therapeutics to Present Phase 1/2 VGA039 Data at ISTH 2026
SOUTH SAN FRANCISCO, Calif., June 26, 2026 Star Therapeutics announced it will present complete safety and efficacy data from...
Sanofi Wins Japan Approval for Wayrilz in Rare Blood Disease
PARIS, June 23, 2026 Sanofi has secured an important regulatory milestone after Japan’s Ministry of Health, Labour and Welfare...
Lilly Jaypirca CHMP Backs EU Approval for CLL Treatment
INDIANAPOLIS, June 26, 2026 Eli Lilly and Company announced that the European Medicines Agency’s Committee for Medicinal Products for...
Advertisements
MaaT Pharma to Seek EMA Re-Examination for Xervyteg After CHMP Rejection
LYON, France, June 26, 2026 MaaT Pharma announced plans to request a re-examination of the European Medicines Agency (EMA)...
Terumo Blood and Cell Technologies Supports New Imara Sickle Cell Framework
NAIROBI, Kenya / KAMPALA, Uganda, June 19, 2026 African health leaders, government officials, clinicians, patient advocates, and international partners...
Incyte Secures Japan Approval for Minjuvi in DLBCL Care
WILMINGTON, Del., June 20, 2026 Incyte Biosciences Japan G.K. has announced that Japan’s Ministry of Health, Labour and Welfare...
Lilly’s Jaypirca Reduces Risk of Disease Progression or Death by 45% in CLL/SLL
INDIANAPOLIS, Indiana, June 14, 2026 Eli Lilly and Company announced compelling results from the pivotal Phase 3 BRUIN CLL-322...
FDA Clears Dexcom Stelo OTC CGM for Children
SILVER SPRING, Maryland, June 12, 2026 The U.S. Food and Drug Administration (FDA) has cleared the Dexcom Stelo Glucose...
Advertisement
